{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Gram Positive Trimethoprim/sulfamethoxazole",
        "VITEK 2 AST-GP SXT"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K050976",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510/S141"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 23, 2005",
    "Summary Letter Received Date": "April 18, 2005",
    "Submission Date": "April 12, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trimethoprim/sulfamethoxazole"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Staphylococcus aureus"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination",
        "Microdilution methodology"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Microdilution"
    ],
    "Submission Type(s)": [
        "Test",
        "Reagent",
        "Card",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Gram Positive Trimethoprim/sulfamethoxazole antimicrobial susceptibility test on VITEK 2 and VITEK 2 Compact systems.",
    "Indications for Use Summary": "Qualitative antimicrobial susceptibility test for Staphylococcus aureus using isolated colonies, with VITEK 2 and VITEK 2 Compact Systems, as a laboratory aid to determine in vitro susceptibility to antimicrobial agents.",
    "fda_folder": "Microbiology"
}